Skip to content

Progression and Risk Prediction of Macrovascular Complications in Type 2 Diabetes Patients under MMC Model: A Retrospective Cohort Study

Progression and Risk Prediction of Macrovascular Complications in Type 2 Diabetes Patients under MMC Model: A Retrospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112912
Enrollment
Unknown
Registered
2025-11-20
Start date
2025-07-21
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic macrovascular complications

Interventions

Sponsors

Affiliated Qidong Hospital of Nantong University/Qidong People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Type 2 diabetes patients meeting the WHO 1999 diagnostic criteria for diabetes;2.Participants engaged in MMC management for =3 years with complete medical records (including but not limited to glycemic, lipid, and blood pressure profiles).

Exclusion criteria

Exclusion criteria: 1. Patients with type 1 diabetes or specific types of diabetes; 2. Patients with incomplete or missing critical data (e.g., lack of key follow-up records or primary endpoint data); 3. Comorbid severe systemic diseases: including end-stage renal disease (ESRD), liver cirrhosis, atrial fibrillation, or other conditions significantly affecting prognosis; 4. Pre-existing severe macrovascular complications (e.g., myocardial infarction, massive stroke, or peripheral arterial occlusion diagnosed at baseline); 5. Hypercoagulable states secondary to hematologic disorders: antiphospholipid syndrome, inherited coagulation disorders, multiple myeloma, polycythemia vera, etc.; 6. Special physiological status: pregnancy or lactation; 7. Autoimmune diseases: systemic lupus erythematosus (SLE), rheumatoid arthritis, or vasculitis of other etiologies; 8. Active malignancies; 9. Psychiatric disorders compromising self-care capacity, cognitive impairment, or inability to comply with the protocol; 10. Uncontrolled hyperthyroidism or other endocrine disorders.

Design outcomes

Primary

MeasureTime frame
Ultrasonographic findings of carotid and major extremity arteries;Ankle-brachial index (ABI);Brachial-ankle pulse wave velocity (baPWV);Head CT/MRI;Coronary CTA;

Secondary

MeasureTime frame
Glycated hemoglobin (HbA1c);Blood pressure;Blood lipids;Body mass index (BMI);Waist-to-Hip (WHR);

Countries

China

Contacts

Public ContactLi Xiaofeng

Affiliated Qidong Hospital of Nantong University/Qidong People’s Hospital

112067639@qq.com+86 159 6289 4343

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026